drugset / Trial / NCT02197156

A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

NCT02197156 ↗

Phase 2 Completed 241 enrolled Zogenix, Inc.
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of the study is to establish a dose-response relationship among several capsule strengths of Hydrocodone Bitartrate Extended Release (HC-ER) and to compare the efficacy to placebo following bunionectomy surgery

Timeline

Start
2002-08
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 325 mg —
Comparator Hydrocodone Unknown 10 mg —
Comparator Hydrocodone Unknown 20 mg —
Comparator Hydrocodone Unknown 30 mg —
Comparator Hydrocodone Unknown 40 mg —

Indications

No indication recorded.